Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201112026 Principal Investigator: Schroeder, Mark
Title: A Phase I/II Study Evaluating the Safety and Efficacy of Intravenous POL6326 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies
Phase: I/II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to see whether donors who are treated with the new drug POL6326 are able to produce enough stem cells for transplant after one dose of the study drug (as compared to other drugs used for the same purpose, which may require multiple collections). We are also looking at the side effects that the donors experience when they’re given POL6326 and whether stem cells collected after donors receive POL6326 are tolerated by recipients.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)